Figure 2From: A study of gene expression markers for predictive significance for bevacizumab benefit in patients with metastatic colon cancer: a translational research study of the Hellenic Cooperative Oncology Group (HeCOG) Objective response rate by (ALDH6A1 + TFF2 + MCM5) gene expression in Bevacizumab qPCR set. Back to article page